𝛼SK or Search

ENTITY

Ultragenyx Pharmaceutical (RARE US)

9

Analysis

Health Care • United States

Ultragenyx Pharmaceutical Inc. provides biotechnology services. The Company develops therapeutics and sialic acid for treating metabolic, body myopathy, glucuronidase, and rare genetic diseases. Ultragenyx Pharmaceutical conducts its business in the United States.

more

Refresh

Exchange Announcement • 14 Oct 2026 21:00

Current Report (Form 8-K | Period ending 2026-10-08)

Exchange Announcement • 07 Oct 2026 21:00

Current Report (Form 8-K | Period ending 2026-10-06)

Exchange Announcement • 18 Sep 2026 03:55

Current Report (Form 8-K | Period ending 2026-09-17)

Exchange Announcement • 03 Sep 2026 04:04

Current Report (Form 8-K | Period ending 2026-09-02)

Exchange Announcement • 20 Aug 2026 05:24

Current Report (Form 8-K | Period ending 2026-08-19)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x